News
DelveInsight’s, “Klebsiella Pneumoniae Infections Pipeline Insight, 2025” report provides comprehensive insights about 10+ companies and 12+ pipeline drugs in Klebsiella Pneumoniae ...
Background: The ST11 clone of carbapenem-resistant Klebsiella pneumoniae (CRKP) has emerged as a major public health threat, driving hospital outbreaks across China and contributing to chronic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback